OK good news, we will get some new analyses on the weekend. I'm just speculating, but reading the release sounds like they may be focusing on the wearable data analyses this weekend, perhaps full analysis for trial could still be getting completed for orphan conference (22nd -24th Boston) or MSA conference (25th London) toward end of April. Cheers for digging those up Scott. Of course no way of knowing but.
But we do know the 201 data will at least show both 434 groups led to; greater step count, more bouts of walking, total walking time and standing time vs placebo, so if we do get the wearable data I'm hoping should look convincing and hopefully be received well by the market.
ATH Price at posting:
0.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)